PMVP
Price
$0.90
Change
-$0.00 (-0.00%)
Updated
May 23, 04:57 PM (EDT)
Capitalization
46.76M
76 days until earnings call
SGMO
Price
$0.47
Change
-$0.03 (-6.00%)
Updated
May 23, 04:59 PM (EDT)
Capitalization
121.35M
81 days until earnings call
Interact to see
Advertisement

PMVP vs SGMO

Header iconPMVP vs SGMO Comparison
Open Charts PMVP vs SGMOBanner chart's image
PMV Pharmaceuticals
Price$0.90
Change-$0.00 (-0.00%)
Volume$296
Capitalization46.76M
Sangamo Therapeutics
Price$0.47
Change-$0.03 (-6.00%)
Volume$62.13K
Capitalization121.35M
PMVP vs SGMO Comparison Chart
Loading...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PMVP vs. SGMO commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMVP is a Hold and SGMO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 24, 2025
Stock price -- (PMVP: $0.90 vs. SGMO: $0.50)
Brand notoriety: PMVP and SGMO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PMVP: 0% vs. SGMO: 0%
Market capitalization -- PMVP: $46.76M vs. SGMO: $121.35M
PMVP [@Biotechnology] is valued at $46.76M. SGMO’s [@Biotechnology] market capitalization is $121.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $307B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PMVP’s FA Score shows that 1 FA rating(s) are green whileSGMO’s FA Score has 0 green FA rating(s).

  • PMVP’s FA Score: 1 green, 4 red.
  • SGMO’s FA Score: 0 green, 5 red.
According to our system of comparison, PMVP is a better buy in the long-term than SGMO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PMVP’s TA Score shows that 5 TA indicator(s) are bullish while SGMO’s TA Score has 4 bullish TA indicator(s).

  • PMVP’s TA Score: 5 bullish, 3 bearish.
  • SGMO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PMVP is a better buy in the short-term than SGMO.

Price Growth

PMVP (@Biotechnology) experienced а +7.55% price change this week, while SGMO (@Biotechnology) price change was +11.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.05%. For the same industry, the average monthly price growth was +3.15%, and the average quarterly price growth was -3.91%.

Reported Earning Dates

PMVP is expected to report earnings on Aug 07, 2025.

SGMO is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGMO($121M) has a higher market cap than PMVP($46.8M). PMVP YTD gains are higher at: -40.305 vs. SGMO (-50.980). PMVP has higher annual earnings (EBITDA): -87.97M vs. SGMO (-123.99M). PMVP has more cash in the bank: 160M vs. SGMO (39.2M). PMVP has less debt than SGMO: PMVP (1.11M) vs SGMO (27.7M). SGMO has higher revenues than PMVP: SGMO (52.3M) vs PMVP (0).
PMVPSGMOPMVP / SGMO
Capitalization46.8M121M39%
EBITDA-87.97M-123.99M71%
Gain YTD-40.305-50.98079%
P/E RatioN/AN/A-
Revenue052.3M-
Total Cash160M39.2M408%
Total Debt1.11M27.7M4%
FUNDAMENTALS RATINGS
SGMO: Fundamental Ratings
SGMO
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PMVPSGMO
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 3 days ago
74%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TLGPY15.120.06
+0.40%
Telstra Group Limited
JBAXY13.01-0.02
-0.15%
Julius Baer Group Ltd.
LRLCF424.30-16.07
-3.65%
L'Oreal Co.
UBSFY2.17-0.11
-4.82%
UbiSoft Entertainment Inc.
DMGGF0.20-0.02
-8.32%
DMG Blockchain Solutions Inc.

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with RCKT. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
N/A
RCKT - PMVP
47%
Loosely correlated
N/A
XNCR - PMVP
42%
Loosely correlated
+2.26%
COGT - PMVP
39%
Loosely correlated
N/A
CLLS - PMVP
39%
Loosely correlated
N/A
RGNX - PMVP
38%
Loosely correlated
N/A
More

SGMO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMO has been loosely correlated with AXON. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMO
1D Price
Change %
SGMO100%
N/A
AXON - SGMO
51%
Loosely correlated
N/A
ARRY - SGMO
48%
Loosely correlated
N/A
BCRX - SGMO
46%
Loosely correlated
+3.18%
RPRX - SGMO
45%
Loosely correlated
N/A
AGEN - SGMO
43%
Loosely correlated
N/A
More